Key result
Mediterranean, DASH, and high-quality plant-based dietary patterns improve cardiovascular risk factors, whereas Western and ultra-processed-food patterns are associated with increased ASCVD risk.
Why the study?
Atherosclerotic cardiovascular disease remains the leading global cause of death, and diet represents an important modifiable target for prevention alongside expanding pharmacological options and advances in metabolomic profiling.
Do healthy dietary patterns reduce atherosclerotic cardiovascular disease risk and improve cardiometabolic risk factors compared with Western and ultra-processed-food dietary patterns?
Do healthy dietary patterns reduce atherosclerotic cardiovascular disease risk and improve cardiometabolic risk factors compared with Western and ultra-processed-food dietary patterns?
This review highlights that whole-diet patterns like Mediterranean, DASH, and plant-based diets remain central to ASCVD prevention alongside expanding pharmacological therapies.
Answers are grounded in this paper and cite their sources.
Supports dietary pattern counseling in ASCVD prevention; leaves open long-term outcome data for alternative regimens.
Atherosclerotic cardiovascular disease (ASCVD) remains the leading global cause of death, and diet represents an important modifiable target for prevention. Contemporary evidence supports a shift from nutrient-based to dietary-pattern approaches with Mediterranean, DASH and high-quality plant-based diets associated with favourable effects on cardiovascular risk factors, including lipid profiles, inflammation, blood pressure and metabolic health. Conversely, Western and ultra-processed-food patterns are associated with increased ASCVD risk, potentially mediated through dyslipidaemia, visceral adiposity, inflammation and oxidative stress. Additional dietary approaches, including the Nordic, Portfolio, low-carbohydrate and intermittent fasting diets, have demonstrated effects on selected cardiometabolic risk factors, although evidence for long-term cardiovascular outcomes remains limited. Advances in metabolomic profiling provide further insight into diet-related cardiometabolic risk and may facilitate further precision-nutrition approaches. Concurrently, glucagon-like peptide-1 receptor agonists and SGLT2 inhibitors have expanded therapeutic options for cardiovascular risk reduction. Reducing the global ASCVD burden requires integration of dietary, pharmacological, clinical and policy strategies. Nutrition should remain central to ASCVD prevention rather than a secondary adjunct.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) conducted a review in Atherosclerotic cardiovascular disease (ASCVD). Dietary patterns (Mediterranean, DASH, high-quality plant-based, Nordic, Portfolio, low-carbohydrate, and intermittent fasting diets) vs. Western and ultra-processed-food dietary patterns was evaluated on Atherosclerotic cardiovascular disease risk and cardiometabolic risk factors (lipid profiles, inflammation, blood pressure, metabolic health). Mediterranean, DASH, and high-quality plant-based dietary patterns improve cardiovascular risk factors, whereas Western and ultra-processed-food patterns are associated with increased ASCVD risk.
Synapse has enriched 10 related papers. Consider them for comparative context: